Long Term Survival of Ischemic Heart Disease Patients Who Undergo Percutaneous Coronary Intervention

Aaron Nethercott, Mercer University College of Pharmacy

Ischemic heart disease (IHD) accounted for almost 380,000 deaths in 2010. According to the 2012 American College of Cardiology Foundation/American Heart Association/American College of Cardiology/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons guidelines for the diagnosis and management of patents with stable ischemic heart disease, the medical management for IHD consists of aspirin, combinations of beta blockers and calcium channel blockers, blood pressure control, and smoking cessation.  The studies reviewed by the guidelines found no difference in survival or myocardial infarction rates between patients who received percutaneous coronary intervention (PCI) and standard medical therapy. Angina in patients with IHD has been shown to be reduce by PCI. [1]

Continue reading